SCHEMBL26420566

SCHEMBL26420566

c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccc5c(c4)oc4cccc(-c6ccc(-c7nc(-c8ccccc8)nc(-c8ccccc8-c8ccccc8)n7)cc6)c45)cc3)cc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR55 Q9Y2T6 1/20 0.32
MAPT P10636 2/20 0.32
NR1H4 Q96RI1 1/20 0.32
BACE1 P56817 1/20 0.31
MEN1 O00255 3/20 0.31
ALDH1A1 P00352 3/20 0.31
KMT2A Q03164 3/20 0.31
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 1/20 0.31
ADORA3 P0DMS8 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA2B P29275 1/20 0.30
ADORA1 P30542 1/20 0.30
THRB P10828 1/20 0.30
RECQL P46063 1/20 0.30
BLM P54132 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420455 0.98 CRHR1 (0.32) GPR55MAPTNR1H4MEN1ALDH1A1
SCHEMBL26420574 0.97 GPR55 (0.32) GPR55MAPTNR1H4BACE1MEN1
SCHEMBL26420474 0.97 CRHR1 (0.33) GPR55MAPTNR1H4MEN1ALDH1A1
SCHEMBL26416682 0.97 MAPT (0.33) GPR55MAPTNR1H4BACE1MEN1
SCHEMBL24746383 0.94 HCRTR1 (0.33) GPR55MAPTNR1H4BACE1MEN1
SCHEMBL26420586 0.94 MAPT (0.32) MAPTNR1H4MEN1ALDH1A1KMT2A
SCHEMBL24255591 0.94 MAPT (0.33) MAPTNR1H4MEN1ALDH1A1KMT2A
SCHEMBL26420463 0.94 MAPT (0.33) MAPTNR1H4MEN1ALDH1A1KMT2A
SCHEMBL24255592 0.94 MAPT (0.33) MAPTNR1H4MEN1ALDH1A1KMT2A
SCHEMBL26420579 0.93 HCRTR1 (0.32) MAPTNR1H4BACE1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 GPR55 2829/4885MAPT 340/4885NR1H4 3135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.